Ardelyx, Inc. (ARDX) stock
ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3059% below fair value
$3.09−0.03 (-0.96%)
Close on Nov 13, 2026Market cap $769.99MP/E –Yield –
Ardelyx gross margin
Gross margin is gross profit as a percentage of revenue.
Ardelyx's gross margin for the twelve months ending Jun 30, 2026 was 94.4%. For fiscal 2025 it was 90.3%, against 84.8% the year before. The highest annual figure on record is 100.0% in fiscal 2015.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 90.3% | +5.4 |
| FY2024 | Dec 31, 2024 | 84.8% | −0.9 |
| FY2023 | Dec 31, 2023 | 85.7% | −6.4 |
| FY2022 | Dec 31, 2022 | 92.1% | +2.0 |
| FY2021 | Dec 31, 2021 | 90.1% | −8.0 |
| FY2020 | Dec 31, 2020 | 98.1% | +9.4 |
| FY2019 | Dec 31, 2019 | 88.6% | +6.5 |
| FY2018 | Dec 31, 2018 | 82.1% | +2.1 |
| FY2017 | Dec 31, 2017 | 80.0% | −20.0 |
| FY2015 | Dec 31, 2015 | 100.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 95.2% | +7.9 |
| Q1 FY2026 | Mar 31, 2026 | 94.9% | +11.5 |
| Q4 FY2025 | Dec 31, 2025 | 91.3% | +7.1 |
| Q3 FY2025 | Sep 30, 2025 | 96.4% | +12.4 |
| Q2 FY2025 | Jun 30, 2025 | 87.3% | +0.2 |
| Q1 FY2025 | Mar 31, 2025 | 83.4% | −1.1 |
| Q4 FY2024 | Dec 31, 2024 | 84.3% | −1.0 |
| Q3 FY2024 | Sep 30, 2024 | 84.0% | −2.4 |
| Q2 FY2024 | Jun 30, 2024 | 87.1% | +2.7 |
| Q1 FY2024 | Mar 31, 2024 | 84.5% | −2.0 |
| Q4 FY2023 | Dec 31, 2023 | 85.2% | −7.6 |
| Q3 FY2023 | Sep 30, 2023 | 86.4% | +1.0 |
| Q2 FY2023 | Jun 30, 2023 | 84.4% | −10.2 |
| Q1 FY2023 | Mar 31, 2023 | 86.5% | +4.6 |
| Q4 FY2022 | Dec 31, 2022 | 92.8% | −7.2 |
| Q3 FY2022 | Sep 30, 2022 | 85.3% | −14.7 |
| Q2 FY2022 | Jun 30, 2022 | 94.5% | −5.5 |
| Q1 FY2022 | Mar 31, 2022 | 81.8% | −3.0 |
| Q4 FY2021 | Dec 31, 2021 | 100.0% | +0.2 |
| Q3 FY2021 | Sep 30, 2021 | 100.0% | +0.0 |
| Q2 FY2021 | Jun 30, 2021 | 100.0% | +7.7 |
| Q1 FY2021 | Mar 31, 2021 | 84.8% | −15.2 |
| Q4 FY2020 | Dec 31, 2020 | 99.8% | −0.2 |
| Q3 FY2020 | Sep 30, 2020 | 100.0% | +19.9 |
| Q2 FY2020 | Jun 30, 2020 | 92.3% | −7.7 |
| Q1 FY2020 | Mar 31, 2020 | 100.0% | +0.0 |
| Q4 FY2019 | Dec 31, 2019 | 100.0% | +1.2 |
| Q3 FY2019 | Sep 30, 2019 | 80.1% | −19.9 |
| Q2 FY2019 | Jun 30, 2019 | 100.0% | +20.0 |
| Q4 FY2018 | Dec 31, 2018 | 100.0% | +20.0 |
| Q3 FY2018 | Sep 30, 2018 | 98.8% | – |
| Q2 FY2018 | Jun 30, 2018 | 100.0% | – |
| Q1 FY2018 | Mar 31, 2018 | 80.0% | – |
| Q4 FY2017 | Dec 31, 2017 | 80.0% | – |
See a number that looks wrong?